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Background. Although several neurophysiological models have been proposed for panic disorder with agoraphobia
(PD/AG), there is limited evidence from functional magnetic resonance imaging (fMRI) studies on key neural networks
in PD/AG. Fear conditioning has been proposed to represent a central pathway for the development and maintenance of
this disorder; however, its neural substrates remain elusive. The present study aimed to investigate the neural correlates
of fear conditioning in PD/AG patients.
Method. The blood oxygen level-dependent (BOLD) response was measured using fMRI during a fear conditioning
task. Indicators of differential conditioning, simple conditioning and safety signal processing were investigated in
60 PD/AG patients and 60 matched healthy controls.
Results. Differential conditioning was associated with enhanced activation of the bilateral dorsal inferior frontal gyrus
(IFG) whereas simple conditioning and safety signal processing were related to increased midbrain activation in PD/AG
patients versus controls. Anxiety sensitivity was associated positively with the magnitude of midbrain activation.
Conclusions. The results suggest changes in top-down and bottom-up processes during fear conditioning in PD/AG that
can be interpreted within a neural framework of defensive reactions mediating threat through distal (forebrain) versus
proximal (midbrain) brain structures. Evidence is accumulating that this network plays a key role in the aetiopatho-
genesis of panic disorder.
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Introduction
Panic disorder (PD) is a particularly severe and costly
anxiety disorder, affecting approximately 7.8 million
people in Europe (Wittchen et al. 2011). Patients experi-
ence recurrent and sudden attacks of intense anxiety
and concerns about their potential implications, often
followed by agoraphobia (AG), the avoidance of
situations in which escape or help may not be available
(APA, 2000). Ranking among the 10 most burden-
some psychiatric and neurological diseases in the
reproductive years, PD is one of most disabling anxiety
disorders (Wittchen et al. 2011).
Fear conditioning has been proposed as a core pro-
cess for the development and maintenance of PD/AG
(Bouton et al. 2001). Interoceptive conditioning, where
the accompanying physiological symptoms during a
panic attack become conditioned stimuli, is linked to
interoceptive symptoms in PD whereas exteroceptive
conditioning is associated with agoraphobic behaviour
(Bouton et al. 2001). However, the particular nature of
the underlying conditioning deficit in PD/AG remains
elusive.
During fear conditioning, a neutral stimulus is paired
repeatedly with an aversive unconditioned stimulus
(US). The neutral stimulus gradually becomes a con-
ditioned stimulus (CS), which elicits a conditioned
fear response signalling the anticipation of the US.
Different learning processes are indexed by differential
conditioning, simple conditioning and safety signal
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processing. Differential conditioning includes a second
CS that is not paired with the US and acquires safety
signal properties (CS−). Conditioned responses are
indexed by the difference between the two CSs, thus
representing the relative difference of the two processes
involved (e.g. discriminatory conditioning): fear con-
ditioning towards the CS+ and fear inhibition towards
the CS−. By contrast, simple conditioning evaluates
conditioning effects of the CS against a preconditioning
baseline, assessing mere association of a CS with the
US independent of discriminatory capabilities. During
safety signal processing, the capacity to inhibit a fear
response in the presence of a safety signal (CS−) is
assessed. Failure to inhibit the conditioned response
could result in pathological overgeneralization of
fear (Lissek, 2012). Using exteroceptive conditioning
tasks, enhanced simple conditioning (Lissek et al.
2005), deficient safety signal processing (Lissek et al.
2009) or increased resistance to extinction learning,
evidencing more persistent recall of the conditioned
response (Michael et al. 2007) has been suggested to
account for learning deficits in PD.
The neural network of fear conditioning has been
extensively studied in humans using functional mag-
netic resonance imaging (fMRI; for a review see
Sehlmeyer et al. 2009). Extending animal research
focusing on the amygdala as a key region (LeDoux
et al. 1988), fMRI studies have revealed a cortical
and subcortical network encompassing the thalamus,
amygdala, hippocampus, insula, anterior cingulate
cortex (ACC) and prefrontal/orbitofrontal cortex
(PFC/OFC) involved in human fear conditioning
(Sehlmeyer et al. 2009). This network has substantial
overlap with fear circuitry structures that show abnor-
mal activation in different anxiety disorders (Etkin &
Wager, 2007; Shin & Liberzon, 2010), further support-
ing the suitability of fear conditioning as a behavioural
probe to investigate the neural substrates of anxiety
disorders (Gorman et al. 2000). Although fear circuitry
dysfunctions in a network that includes the amygdala,
hippocampus, thalamus, hypothalamus, periaqueduc-
tal grey (PAG) and locus coeruleus (Gorman et al.
2000) have been proposed in the pathogenesis of PD,
models so far are mainly based on animal work and
thus of primarily heuristic value for human subjects.
Furthermore, these models have rarely been tested
empirically according to the dysfunctional processes
of interest (e.g. fear conditioning). In accordance with
behavioural studies on fear conditioning (Lissek et al.
2009), altered neural processing of safety cues in PD
has been suggested, with less activation during
instructed threat and increased activity during the
safe condition in the subgenual cingulate, ventral stria-
tum and extended amygdala, and in the midbrain PAG
(Tuescher et al. 2011).
Based on these findings we aimed to elucidate
neural substrates of exteroceptive fear conditioning in
PD/AG patients. Regarding the still undefined nature
of the learning deficit, we tested different hypotheses
focusing on a particular conditioning process; that is,
enhanced differential conditioning, enhanced simple
conditioning and altered safety signal processing.
Based upon previous work on the neural substrates
of fear conditioning in general (Sehlmeyer et al. 2009),
and altered safety signal processing in PD (Tuescher
et al. 2011), we expected patients to exhibit enhanced
neural activity in fear circuit structures according to
the above-described conditioning processes encom-
passing the amygdala, thalamus, midbrain, insula,
ACC and prefrontal cortex (PFC) when compared to
controls. A positive association with anxiety sensi-
tivity, which has been suggested as a subclinical trait
marker of PD (Schmidt et al. 2006; Bernstein et al.
2009), was expected.
Method
Subjects
The study was part of the national research network
PANIC-NET (Gloster et al. 2009). Four centres
(Aachen, Berlin-Charité, Dresden and Münster) partici-
pated in the fMRI study. Present data are based on a
baseline assessment prior to treatment. Results on
neural correlates of treatment-related changes have
been reported elsewhere (Kircher et al. 2013). Quality
controlled data from 60 patients and 60 healthy con-
trols were included in the analysis. Patients and con-
trols were matched for age (± 5 years), gender and
handedness (Edinburgh Handedness Inventory, EHI;
Oldfield, 1971). Patient inclusion criteria encom-
passed a primary diagnosis of PD/AG according to
DSM-IV-TR criteria as assessed by the Composite
International Diagnostic Interview (CAPI-WHO-CIDI;
DIAX-CIDI version; Wittchen & Pfister, 1997), which
was validated by clinical experts, a score 518 on the
structured interview guide for the Hamilton Anxiety
Rating Scale (SIGH-A; Shear et al. 2001), a score 54
at the Clinical Global Impressions Scale (CGI; Guy,
1976), and age between 18 to 65 years. Clinically
significant suicidal intent, any psychotic or bipolar
disorder, borderline personality disorder, current
drug dependence or a medical disease that could
explain the patient’s symptoms were followed by
exclusion. Other current co-morbid diagnoses, includ-
ing unipolar depression and other anxiety disorders,
were allowed unless they were of primary clinical con-
cern. As such, this sample can be considered as both
relatively severe and representative of patients seen
in clinical practice. Patients had to discontinue all
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psychopharmacological medication; patients on psy-
chotropic medication underwent a wash-out period
of 4 weeks before inclusion. Control subjects were
free of current or past medical, neurological or psychi-
atric illness, as evidenced by the CAPI-WHO-CIDI;
DIAX-CIDI version. Exclusion criteria for both groups
were pregnancy, cardiac pacemaker, ferromagnetic
metal implants, tattoos or permanent make-up with
ferromagnetic colours. After complete description of
the study, subjects provided informed written consent.
The study was approved by the ethics committees of
all participating centres.
fMRI task
The task design has been described in detail elsewhere
(Reinhardt et al. 2010; Kircher et al. 2013). In brief, we
used a differential fear conditioning task that consisted
of three phases: familiarization (F) with 16 trials,
acquisition (A) with 32 trials, and extinction (E) with
16 trials of each CS [coloured geometrical forms;
presentation time 2000ms with a variable inter-trial
interval (ITI) of 4.785 to 7.250 s] and an aversive tone
(white noise; 100ms) as the US between 70 and
105 dB. Depending on individual judgements of
aversiveness, subjects scoring <5 on a 10-point Likert
scale were excluded to control for potential non-
responders. In the acquisition, the US was paired
pseudo-randomly with one of the CSs (counter-
balanced between subjects; partial reinforcement rate
of 50%), resulting in equal proportions of CS+ paired
and CS+ unpaired trials. To avoid confounding effects
between the CS+ and US processing, only CS+
unpaired trials were analysed during acquisition.
After each phase, subjective valence and arousal rat-
ings using the Self-Assessment Manikin (SAM;
Bradley & Lang, 1994) for both CSs were obtained
using a five-point Likert scale (for valence: 1, ‘very
unpleasant’ to 5, ‘very pleasant’; and for arousal:
1, ‘not arousing’ to 5, ‘very arousing’). Because of tech-
nical problems, the ratings of one patient and two
healthy control subjects were missing. Task duration
was 16min 49 s. Stimuli were presented by MR-
compatible LCD goggles or back-projection systems
and standard headphones using Presentation 11
(Neurobehavioral Systems; www.neurobs.com).
fMRI data acquisition and analysis
A detailed description of measures for quality
control in this multicentre study is given in Kircher
et al. (2013). Images were acquired using 3-T
Philips Achieva (Aachen and Münster), 3-T Siemens
Trio (Dresden) and 3-T General Electric Healthcare
(Berlin) scanners. Five-hundred and five axial func-
tional images [echo-planar imaging (EPI): matrix
64 ×64, 30 slices interleaved, field of view (FOV)=230,
voxel size=3.6×3.6×3.8mm, echo time (TE)=30ms,
repetition time (TR)=2 s] covering the whole brain
and positioned parallel to the intercomissural line
(AC–PC) were recorded, along with a three-
dimensional (3D) structural data set [magnetization
prepared rapid gradient echo (MPRAGE): matrix
128×112, 88 slices, FOV=256, voxel size=2×2×2mm,
TE=3.93ms, TR=1100ms, flip angle=9°]. MR images
were analysed using Statistical Parametric Mapping
(SPM5; www.fil.ion.ucl.ac.uk) implemented in
MATLAB 6.5 (Mathworks Inc., USA). The first five
volumes were discarded to minimize T1 saturation
effects. Data were filtered to 1/128 Hz to remove low-
frequency noise. Slice time correction was performed,
shifting the signal measured in each slice relative to
the acquisition time of the middle slice. Functional
images were temporally and spatially aligned and nor-
malized into standard stereotactic space (2×2×2mm).
To account for differences in intrinsic smoothness
between scanners, an iterative smoothness equaliza-
tion procedure (Friedman et al. 2006) was performed
using 12-mm full-width at half-maximum (FWHM)
Gaussian isotropic kernel smoothing. Thus, data from
all centres were smoothed iteratively until a smooth-
ness of 12-mm FWHM was reached, independent
of scanner-specific intrinsic smoothness of the data.
Assuming an intrinsic smoothness of 4–6mm, a com-
parable smoothness would be obtained by applying
a predefined kernel of 8-mm FWHM in a normal
smoothing procedure.
At the first level, realignment parameters were
included as regressors of no interest into the model
to account for movement artefacts. The blood oxygen
level-dependent (BOLD) response for each event type
(CS+ paired, CS+ unpaired, CS−, US) and phase
(F, A, E) was modelled by the canonical haemo-
dynamic response function within the framework of
the general linear model to analyse brain activation
differences related to the onset of the different stimuli.
Phases were further split into first and second halves
(e.g. F1, F2, A1, A2, E1, E2). The second half of the
familiarization (F2) was used as a baseline for CS+
and CS− for contrasts on simple conditioning and
safety signal processing, assuming that orienting re-
actions should have decayed during the late phase.
Regressors for the acquisition and extinction were
again collapsed. Parameter estimates (β) and t statistic
images were calculated. At the second level, a group
analysis was performed by entering contrast images
into a flexible factorial analysis, in which subjects
were treated as random variables. fMRI centre vari-
ables were introduced as covariates of no interest to
account for scanner differences between sites. Further
covariates of no interest included education level,
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where we found group differences, and the Beck
Depression Inventory Second Edition (BDI-II; Beck
et al. 1996), which might confound panic sympto-
matology in the current sample. However, analyses
without the BDI-II score yielded comparable patterns
of brain activation.
Contrasts of interest
We first tested for general conditioning effects in con-
trols, patients and the combined sample in the acqui-
sition and extinction phases (A: CS+ unpaired>CS−;
E: CS+ unpaired>CS−). We then investigated group
differences in differential fear conditioning (A: PD/
AG>controls: CS+ unpaired>CS−; E: PD/AG>con-
trols: CS+ unpaired>CS−), simple fear conditioning
(A: PD/AG>controls: CS+ unpaired>CS+ familiariz-
ation; E: PD/AG>controls: CS+ unpaired>CS+ fam-
iliarization) and safety signal processing (A: PD/AG>
controls: CS–>CS– familiarization; E: PD/AG>con-
trols: CS–>CS– familiarization). Because of the lack
of evidence on neural correlates of fear conditioning
in PD/AG, a whole-brain analysis was carried out
first. Post-hoc region-of-interest (ROI) analyses were
performed for the amygdala to ensure that activity of
the amygdala was not excluded because of the large
cluster threshold. As early habituation of this structure
has been reported (Büchel et al. 1998), amygdala
activity during the first half of the acquisition phase
was investigated separately. Estimated β values from
activation clusters were extracted for illustration of
box plots. Pearson’s correlations were carried out
between estimated β values and anxiety sensitivity
scores as indicated by the Anxiety Sensitivity Index
(ASI; Reiss et al. 1986). A Monte Carlo simulation
was conducted to establish an appropriate voxel conti-
guity threshold (Slotnick et al. 2003). This procedure
relies on the fact that, given spurious activity or noise
(voxel-wise type I error), the probability of observing
increasingly large (spatially contiguous) clusters of
activity decreases systematically. A cluster extent
threshold can be enforced to ensure an acceptable
probability of cluster-wise type I error (Slotnick &
Schacter, 2004). This correction has the advantage of
higher sensitivity to smaller effect sizes, while still
correcting for multiple comparisons across the whole-
brain volume. The result of the Monte Carlo simu-
lations was based on the 2×2×2mm interpolated
voxels, the 12-mm smoothing kernel, the FOV and
the number of slices. Assuming an individual voxel
type I error of p<0.005, a cluster extent of 142 contigu-
ous resampled voxels was indicated as sufficient to
correct for multiple voxel comparisons at p<0.05.
Thus, for all analyses, voxels with a significance level
of p<0.005 uncorrected belonging to clusters with at
least 142 voxels are reported (see also Kircher et al.
2013). For conjunction analyses against the null
hypothesis (Nichols et al. 2005), a minimum cluster
size of 30 voxels was used.
Sample characteristics were tested using χ2 and
t tests (two-tailed). Subjective ratings were analysed
with three-factorial ANOVAs for repeated measures
and two-tailed pairwise comparisons with the two
within-subject factors phase (F; A; E) and stimulus
(CS+; CS−) and the between-subjects factor group
(patients; controls). Post-hoc analyses were also
conducted separately for patients and controls.
Greenhouse–Geisser corrections were used when
appropriate. An α level of p<0.05 indicated statistical
significance; analyses were carried out using IBM
SPSS 19.0 (IBM Corp., USA).
Results
Sample characteristics and behavioural data
Sample characteristics are given in Table 1. Although
educational level was lower in patients, groups were
comparable in neuropsychological performance.
Regarding valence (higher values equal positive
valence), a main effect of group indicated significantly
lower ratings for patients throughout the entire exper-
iment (F1,115=17.011, p<0.001). A significant main
effect of phase was observed, with lower ratings after
familiarization and acquisition than after extinction
(F2,209=7.712, p=0.001; F, A<E, p<0.05). The significant
interaction effect phase×CS indicated that differential
acquisition of contingencies had occurred, with CS+
ratings being significantly lower than CS– ratings
after acquisition (F2,218 =10.132, p<0.001; acquisition:
CS+<CS−, p=0.003). Similar results were obtained
for arousal ratings (higher values equal more arousal),
with a main effect of group (F1,115=26.747, p<0.001;
patients>controls), phase (F2,278=3.778, p=0.035; F,
A<E, p<0.05), CS (F1,115 =6.290, p=0.014; CS+>CS−)
and interaction effect phase×CS (F2,206=3.474, p=
0.038; A: CS+>CS−, p=0.002). Separate subgroup
analyses showed that differences were mainly driven
by controls, whereas patients did not discriminate
CS+ and CS− by means of subjective ratings. No
other significant main or interaction effects were
observed (Fig. 1).
fMRI results
Differential conditioning effects in the combined sample
In controls, we observed midbrain activation during
the acquisition phase in response to the CS+>CS−.
In patients, a widespread network encompassing
the bilateral insula, superior temporal gyrus, left
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precentral gyrus and right supplementary motor
area was activated. In the combined sample, a large
cortical and subcortical network encompassing the
superior temporal gyrus [extending to the inferior
frontal gyrus (IFG) and anterior insula], precentral
gyrus, supplementary motor area and midbrain was
activated during fear acquisition. Expression of con-
ditioned fear during extinction revealed a cluster
in the superior medial frontal gyrus extending to
the medial orbitofrontal and anterior cingulate gyri
(Table 2; Fig. 2).
Group differences in differential conditioning, simple
conditioning and safety signal processing
Compared to controls, patients showed enhanced
neural activation for differential conditioning during
acquisition (PD/AG>controls: CS+ unpaired>CS−) in
the bilateral dorsal IFG and right superior frontal
gyrus. Bar graphs indicate that this effect was driven
by enhanced activation towards the CS+ in patients
compared to controls, who did not differ in the magni-
tude of brain activation in this cluster for both CSs.
Simple conditioning (PD/AG>controls: CS+ unpaired
>CS+ familiarization) and safety signal processing
(PD/AG>controls: CS−>CS– familiarization) were
associated with increased neural activity in the mid-
brain in patients (Table 2; Fig. 2). Again, this effect
was driven by increased responding in patients
towards the CS+ unpaired and CS− during acquisition
when compared to the CS+ and CS− during late fam-
iliarization, whereas a relative deactivation was
observed in controls. A conjunction analysis of the
simple conditioning and safety signal processing con-
trasts confirmed that neural activity in the midbrain
was enhanced during both CS+ unpaired and
CS− processing in patients. No differential activation
patterns for these contrasts were observed during
extinction. Exploratory ROI analyses did not yield
differential activity in the amygdala. We further
explored amygdala activation in these contrasts of
interest during the first half of the acquisition
phase. In patients, increased activation during safety
signal processing (A1: CS–>CS– familiarization) was
observed in the left amygdala [Montreal Neurological
Institute (MNI) coordinates: x=−24, y=−2, z=−26;
Table 1. Demographic and clinical characteristics of the sample
Patients (n=60)a Controls (n=60) χ2 or t (df) p
Demographic characteristics
Female gender, n (%) 41 (68.30) 41 (68.30) 0.000 (1) 1.000
Education, n (%)
8 years 4 (6.70) 2 (3.30) 12.473 (2) 0.002
10 years 30 (50.00) 13 (21.70)
12–13 years 26 (43.30) 45 (75.0)
Age (years) 36.52 (10.33) 35.75 (10.27) −0.409 (118) 0.683
Neuropsychological characteristics
Digit span forward 7.58 (1.96) 8.17 (1.95) 1.634 (118) 0.105
Digit span backward 7.03 (1.92) 7.10 (2.23) 0.175 (118) 0.861
TMT-A (s) 25.80 (8.38) 23.88 (7.94) −1.286 (118) 0.201
TMT-B (s) 58.06 (18.77) 52.92 (17.68) −1.544 (118) 0.125
US rating 8.08 (1.24) 8.22 (0.90) 0.673 (118) 0.502
Clinical characteristics
CGI 5.37 (0.67) – – –
SIGH-A total 24.42 (5.06) – – –
PAS total 27.29 (8.35) – – –
ASI totalb 31.41 (9.88) 9.07 (7.08) −14.160 (105) < 0.001
BDI-II totalc 17.66 (8.58) 1.37 (2.08) −14.174 (65) < 0.001
TMT-A, Trail Making Test Part A; TMT-B, Trail Making Test Part B; US, unconditioned stimulus (10-point Likert scale);
CGI, Clinical Global Impressions Scale; SIGH-A, structured interview guide for the Hamilton Anxiety Rating Scale; PAS,
Panic and Agoraphobia Scale; ASI, Anxiety Sensitivity Index; BDI-II, Beck Depression Inventory Second Edition; df, degrees
of freedom.
a One patient participated in the functional magnetic resonance imaging (fMRI) study, but did not consent to the
clinical trial.
b Available for n=119.
c Available for n=118.
Values given as mean (standard deviation) except where noted.
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cluster size=147, t=3.34, puncorr. <0.001] during early
acquisition (Fig. 3). Controls showed a small cluster
of amygdala activation during simple conditioning
(A1: CS+>CS+ familiarization) in the right amyg-
dala (x=38, y=4, z=−26; cluster size=2, t=2.65,
puncorr. =0.004). Group comparisons did not yield any
further amygdala activation.
Anxiety sensitivity was positively correlated with
brain activation in the midbrain during simple condi-
tioning, but not with activity in the dorsal IFG during
differential conditioning (patients: rR IFG (56, 26, 10) – ASI =
−0.072, p=0.586; rR midbrain (12, −14, −18) – ASI =
0.288, p=0.027; rR midbrain (12, −14, −20) – ASI=0.006,
p=0.964; controls: rR IFG (56, 26, 10) – ASI =−0.074,
p=0.574; rR midbrain (12, −14, −18) – ASI=0.297, p=0.021;
rR midbrain (12, −14, −20) – ASI=0.0166, p=0.205).
Discussion
Despite an increasing number of studies investigating
the neural correlates of PD (for a review see Dresler
et al. 2012), relatively little is known about the neural
correlates of fear conditioning in these patients.
Behavioural studies have indicated deficient safety sig-
nal processing as a potential marker of PD (Lissek et al.
2005, 2009). Investigating different aspects of fear
conditioning and their neural correlates in PD/AG,
the present study yielded the following key results:
patients showed enhanced bilateral dorsal IFG acti-
vation during differential conditioning whereas simple
conditioning and safety signal processing were associ-
ated with enhanced midbrain activity in PD/AG
patients. These data suggest altered top-down and
bottom-up processing of fear conditioning in PD/AG.
Although subjective ratings indicated that successful
acquisition of contingencies in the combined sample
was driven mainly by controls, patients activated
key structures of the neural network subserving fear
conditioning, such as the bilateral insula, superior
temporal gyrus and premotor cortex during differen-
tial conditioning. In the combined group, we observed
a cortical and subcortical network encompassing
the superior temporal gyrus (extending to the IFG
and anterior insula), precentral gyrus, supplementary
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Fig. 1. Neural and behavioural markers of differential fear conditioning. (a) Brain activation during differential conditioning
[acquisition phase: reinforced conditioned stimulus (CS+ unpaired)>non-reinforced conditioned stimulus (CS−)] in the
combined sample. Clusters encompass the superior temporal gyri (extending to the anterior insula; left figure), precentral gyri
and midbrain (right figure). (b) Behavioural data (valence and arousal ratings) on fear conditioning. *** p<0.001.
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Fig. 2. Group differences in brain activation during differential conditioning [reinforced conditioned stimulus (CS+ unpaired)>non-reinforced conditioned stimulus (CS−)], simple
conditioning (CS+ unpaired>CS+ familiarization) and safety learning (CS–>CS– familiarization). Box plots on estimated β values from the cluster for each regressor are given. F2, the
second half of the familiarization phase; A, the acquisition phase.
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Table 2. Brain activation (clusters and cluster extensions) of fear conditioning for the combined patient and control sample and for patients>
controls
Contrast/region Side Voxels
MNI coordinates
t puncorr.x y z
Controls only
Differential conditioning acquisition phase: CS+ unpaired>CS−
Midbraina L 207 −2 −16 −10 3.57 < 0.001
Differential conditioning extinction phase: CS+ unpaired>CS− No differential activation
Patients only
Differential conditioning acquisition phase: CS+ unpaired>CS−
Insulaa R 2247 38 18 −2 4.19 < 0.001
IFG, pars triangularis R 54 22 16 4.14 < 0.001
IFG, pars triangularis R 54 34 10 3.61 < 0.001
Superior temporal gyrusa R 1219 64 −36 8 3.94 < 0.001
Superior temporal gyrus R 66 −12 −2 3.49 < 0.001
Supramarginal gyrus R 68 −32 24 3.36 < 0.001
Superior temporal gyrusa L 1711 −62 −20 4 3.77 < 0.001
Superior temporal gyrus L −48 −14 0 3.77 < 0.001
Superior temporal gyrus L −50 −28 6 3.76 < 0.001
Precentral gyrusa L 225 −26 −20 70 3.62 < 0.001
Supplementary motor areaa R 293 10 14 52 3.32 < 0.001
IFG, pars triangularisa L 152 −50 30 26 3.31 < 0.001
Insulaa L 325 −32 24 −2 3.27 0.001
Insula L −40 8 −6 3.16 0.001
IFG, pars triangularis L −40 30 10 2.74 0.003
IFG, operculuma L 231 −46 10 28 3.13 0.001
Differential conditioning extinction phase: CS+ unpaired>CS− No differential activation
Combined patient and control sample
Differential conditioning acquisition phase: CS+ unpaired>CS−
Superior temporal gyrusa R 3867 64 −36 10 4.21 < 0.001
Superior temporal gyrus R 62 −12 −4 4.21 < 0.001
IFG, pars triangularis R 42 30 −2 4.00 < 0.001
Superior temporal gyrusa L 1920 −62 −22 10 4.21 < 0.001
Superior temporal gyrus L −52 −16 4 3.80 < 0.001
Superior temporal gyrus L −52 −30 6 3.65 < 0.001
Precentral gyrusa L 233 −24 −20 70 3.49 < 0.001
Midbraina R 261 14 −18 −18 3.40 < 0.001
Midbrain L −4 −16 −12 3.24 0.001
Precentral gyrusa R 183 18 −20 72 3.34 < 0.001
Supplementary motor area R 4 −22 66 2.98 0.001
Precentral gyrus R 28 −26 74 2.91 0.002
Differential conditioning extinction phase: CS+ unpaired>CS−
Putamena L 163 −20 −4 10 3.28 0.001
Superior temporal gyrusa L 153 −60 −12 2 3.09 0.001
Rolandic operculum L −48 −4 6 2.90 0.002
Superior medial frontal gyrusa R 156 10 50 2 3.09 0.001
Medial orbitofrontal gyrus R 12 56 −8 2.95 0.002
Anterior cingulate gyrus R 10 54 10 2.79 0.003
Patients>controls
Differential conditioning acquisition phase: CS+ unpaired>CS−b
IFG, pars triangularisa R 373 56 36 10 4.52 < 0.001
IFG, pars triangularis R 60 24 14 3.34 < 0.001
IFG, pars triangularisa L 507 −50 32 28 4.31 < 0.001
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Table 2 (cont.)
Contrast/region Side Voxels
MNI coordinates
t puncorr.x y z
Superior frontal gyrusa R 170 18 46 32 3.34 < 0.001
Superior frontal gyrus R 20 34 38 2.98 0.001
Simple conditioning acquisition phase: CS+ unpaired>CS+ familiarizationb
Midbraina R 148 12 −14 −18 3.96 < 0.001
Midbraina L 145 −10 −24 −20 3.35 < 0.001
Midbrain L −8 −34 −12 2.96 0.002
Midbrain R 8 −34 −12 2.94 0.002
Safety learning acquisition phase: CS–>CS– familiarizationb
Midbraina R 210 12 −14 −20 4.00 < 0.001
Midbraina L 345 −10 −14 −22 3.59 < 0.001
Midbrain L −22 −20 −2 3.04 0.001
Midbrain L −30 −24 −8 2.87 0.002
Conjunction analysis acquisition phase: (CS+ unpaired>CS+ familiarization) and (CS–>CS– familiarization)c
Midbraina R 132 12 −14 −20 3–91 < 0.001
IFGa L 39 −46 −36 −20 3.50 < 0.001
Differential conditioning extinction phase: CS+ unpaired>CS−b No differential activation
Simple conditioning extinction phase: CS+ unpaired>CS+
familiarizationb
No differential activation
Safety learning extinction phase: CS−>CS– familiarizationb No differential activation
L, Left; R, right; CS+ unpaired, conditioned stimulus associated with the unconditioned stimulus (US) (unpaired trial only);
CS−, CS not associated with the US; IFG, inferior temporal gyrus; Voxel, number of voxels per cluster; MNI, Montreal
Neurological Institute;
a Cluster peak voxels.
b p<0.005 (uncorrected) with a minimum cluster size of 142 contiguous voxels, indicating correction for multiple
comparisons at p<0.05.
c p<0.005 (uncorrected) with a minimum cluster size of 30 contiguous voxels for the conjunction analysis.
Safety signal processing early acquisition; patients only (n = 60)
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Fig. 3. Amygdala activation during safety signal processing [non-reinforced conditioned stimulus (CS–) >CS– familiarization]
in the early acquisition phase (patients only). F2, the second half of the familiarization phase; A1, the first half of the
acquisition phase stimulus; L, left.
Neural correlates of fear conditioning in panic disorder 389
https://doi.org/10.1017/S0033291713000792
Downloaded from https://www.cambridge.org/core. SLUB Dresden, on 03 Feb 2020 at 09:31:24, subject to the Cambridge Core terms of use, available at https://www.cambridge.org/core/terms.
motor area and midbrain involved in differential con-
ditioning. Expression of the conditioned response
during extinction activated the putamen, superior
medial frontal gyrus (extending to the medial OFC
and ACC) and superior temporal gyrus, thus over-
lapping with previous observations on fear condition-
ing networks in the brain (Sehlmeyer et al. 2009). No
amygdala activation was observed during differential
conditioning in the entire group even when applying
a less conservative ROI approach. Converging evi-
dence from animal and human lesion studies exists
that the amygdala is involved in fear acquisition
(LeDoux et al. 1988; Wilensky et al. 2006), but fMRI
studies have demonstrated amygdala involvement
inconclusively, possibly because of its fast habituation
profile and different task characteristics (Sehlmeyer
et al. 2009). Patients showed increased amygdala
activity during safety signal processing. Regarding
PD, other findings do not support the notion of a gen-
erally hyperactive amygdala (Ottaviani et al. 2012), but
the current results could indicate the relevance of
altered safety signal processing that seems to activate
structures associated with the detection of potential
threat. This observation is in accordance with altered
safety signal processing in behavioural studies
(Lissek et al. 2005, 2009). It points to the importance
of fear inhibition in the presence of safety signals, sup-
plementing conventional conditioning analyses that
are restricted to differential conditioning effects.
Comparing patients and controls, the results yielded
increased activation along the neuraxis in response
to the conditioned stimuli, ranging from prefrontal
(IFG) to midbrain structures, as a neural marker of
PD/AG. The right, but also the left, IFG has been
associated with the inhibition of motor responses
during stop-signal tasks (Aron et al. 2003; Swick et al.
2008). A recent study reported activity in the right
IFG pars triangularis to stimuli associated with
stop signals, suggesting that activity in this brain
region can be triggered through associative learning
(Lenartowicz et al. 2011). Hyperactivation in the bi-
lateral IFG in PD/AG patients could be interpreted
in terms of increased behavioural inhibition in the
presence of a stimulus signalling potential threat.
Whereas the IFG is associated with behavioural in-
hibition, the midbrain PAG is an integral part of
the brain system mediating defensive reactivity under
threat (McNaughton & Corr, 2004; Brandao et al.
2008). Somatic, autonomic and behavioural com-
ponents of emotional reactions are coordinated within
the PAG, which itself is controlled by extensive
descending fibres from the medial and orbital PFC,
ACC, insula, amygdala and hypothalamus (Amaral
et al. 1992; An et al. 1998). Although conventional ana-
tomical masking usually does not allow for exact
labelling of the PAG or its substructures (e.g. dorsal
or ventral parts), MNI coordinates (conjunction analy-
sis: x=12, y=−14, z=−20) were similar to those
reported by others on midbrain alterations in PD
patients (Protopopescu et al. 2006: x=6, y=−15,
z=−18; Uchida et al. 2008: x=−11, y=−17, z=−22;
Tuescher et al. 2011: x=6, y=−24, z=−18), indicating
that this area of the midbrain might be involved in
the pathophysiology of PD. Based on animal studies,
neurophysiological models of PD state that the mid-
brain PAG is a key area involved in panic behaviour,
indicating increased defensive reactivity in these
patients (Lovick, 2000; Brandao et al. 2008; Graeff &
Del Ben, 2008). Human structural and functional ima-
ging studies have further corroborated this notion,
showing increased BOLD responses in the midbrain
during safety signal processing (Tuescher et al. 2011)
and increased metabolic activity during anticipatory
anxiety (Boshuisen et al. 2002), in addition to enhanced
grey matter volume in the midbrain and pons in PD
patients (Protopopescu et al. 2006; Uchida et al. 2008;
Fujiwara et al. 2011).
Some studies suggest that the neural substrates of
defensive reactions are organized along a functional
gradient including higher forebrain areas and mid-
brain structures mediating ‘hard-wired’ imminent
threat reactions (McNaughton & Corr, 2004; Mobbs
et al. 2009). A shift from prefrontal to midbrain PAG
activity has been reported with decreasing predatory
distance (Mobbs et al. 2007). When confronted with
the potential presence of an exteroceptive threat (US),
patients activated defensive system structures associ-
ated with imminent threat processing (as indicated
by midbrain activity) in response to both CSs, whereas
relative differences between these stimuli were related
to response inhibition (dorsal IFG), which possibly
indicates threat evaluation processes such as risk assess-
ment or behavioural inhibition (McNaughton & Corr,
2004). In line with these results, we interpret our
current findings in terms of altered top-down (risk
assessment or behavioural inhibition) and bottom-up
(defensive reactivity) processing during fear condition-
ing in PD/AG. This interaction may also indicate
the interplay between instrumental (behavioural inhi-
bition) and Pavlovian conditioning as reflected by
IFG and midbrain activation, by which conditioned
fear drives behavioural avoidance, a hypothesis
that could be tested with instrumental conditioning
designs. In contrast to behavioural studies (Michael
et al. 2007), we did not observe altered neural proces-
sing of extinction learning because group differences
were restricted to the acquisition phase. It should be
noted that the present task focused on fear learning;
future studies should investigate extinction learning
and recall in more detail.
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Midbrain activity during simple conditioning corre-
lated with anxiety sensitivity in patients and controls.
Findings indicate that high-risk markers of panic
behaviour such as anxiety sensitivity are related to
midbrain activity during the processing of stimuli
signalling potential threat, but studies on high-risk
samples are warranted to examine this hypothesis
further.
Our findings should be interpreted within the study
limitations. First, no autonomic marker or US expect-
ancy ratings indicating successful conditioning were
available, and the choice of an auditory US and partial
reinforcement rate could have resulted in relatively
mild conditioning effects. Sympathetic indicators
such as skin conductance (SC) or startle would have
been helpful in further interpreting the present
findings on defensive reactivity in PD/AG. However,
the paradigm itself has been validated in control sub-
jects combining fMRI and SC (Reinhardt et al. 2010).
Regarding this particular patient population that is
very vulnerable to the stress-eliciting properties of
the scanner setting itself (Lueken et al. 2011), there is
a trade-off between the induction of conditioning
effects on the one hand and patient compliance on
the other. We tried to control for non-responders by
excluding subjects below a certain threshold in the
aversiveness rating. Ratings were furthermore compar-
able between patients and controls. Second, no conso-
lidation phases were included in the present task, thus
possibly accounting for the missing group differences
in the extinction phase. Future studies should consider
delayed extinction tasks as a valuable alternative,
although the feasibility of fMRI study designs requir-
ing assessments on consecutive days needs to be pro-
ven in this patient group. Third, missing a patient
control group, the specificity of alterations in fear con-
ditioning for PD/AG has not yet been tested. Studies
applying comparative designs on different anxiety dis-
orders or on high-risk samples are warranted. Finally,
the relevance of anxiety sensitivity could be examined
in more detail using other experimental approaches
closely related to the pathophysiology of PD, such as
interoceptive conditioning.
In conclusion, patients showed enhanced processing
of differential conditioning in the dorsal IFG, while at
the same time exhibiting enhanced responses to either
the CS+ unpaired or CS− in the midbrain. This acti-
vation pattern might indicate altered top-down and
bottom-up processing during fear conditioning in
PD/AG. Our findings can be interpreted within a
neural framework of defensive reactivity being hier-
archically organized from prefrontal (potential threat)
to midbrain (proximal threat) defensive mechanisms
that seems to play a key role in the aetiopathogenesis
of PD.
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